Skip to content


  • Poster presentation
  • Open Access

Ionotropic GABA receptors: modelling and design of selective ligands

  • 1,
  • 1,
  • 1,
  • 1 and
  • 1
Journal of Cheminformatics20102 (Suppl 1) :P49

  • Published:


  • Molecular Dynamic
  • Structural Factor
  • Molecular Modelling
  • Homology Modelling
  • Virtual Screening

Ionotropic GABAA and GABAC receptors play an important role in the operation of CNS and serve as targets for many neuroactive drugs. Using the homology modelling and molecular dynamics, the 3D models of the receptors were built and some aspects of ligand-target interactions were elucidated [1, 2].

To better understand the structural factors controlling the activity and selectivity of the ligands, a series of QSAR models [3] were derived based on the Molecular Field Topology Analysis (MFTA) [4], CoMFA and Topomer CoMFA approaches. They were compared with each other as well as with the molecular modelling results.

Finally, a number of potential selective ligand structures were identified by means of the virtual screening [5] from the available chemicals databases and the generated structure libraries.

Authors’ Affiliations

Department of Chemistry, Moscow State University, Moscow, 119991, Russia


  1. Osolodkin DI, Chupakhin VI, Palyulin VA, Zefirov NS: J Mol Graph Model. 2009, 27: 813-10.1016/j.jmgm.2008.12.004.View ArticleGoogle Scholar
  2. Chupakhin VI, Palyulin VA, Zefirov NS: Doklady Biochem Biophys. 2006, 408: 169-10.1134/S1607672906030173.View ArticleGoogle Scholar
  3. Chupakhin VI, Bobrov SV, Radchenko EV, Palyulin VA, Zefirov NS: Doklady Chemistry. 2008, 422: 227-10.1134/S0012500808090073.View ArticleGoogle Scholar
  4. Palyulin VA, Radchenko EV, Zefirov NS: J Chem Inf Comp Sci. 2000, 40: 659-View ArticleGoogle Scholar
  5. Radchenko EV, Palyulin VA, Zefirov NS: Chemoinformatics Approaches to Virtual Screening. Edited by: Varnek A, Tropsha A. 2008, RSC, 150-181. full_text.View ArticleGoogle Scholar


© Vladimir A et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd.